These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 15262699

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series.
    Charles CA, Leon A, Banta MR, Kirsner RS.
    Int J Dermatol; 2007 Oct; 46(10):1095-9. PubMed ID: 17910724
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intravenous cyclophosphamide pulses in pyoderma gangrenosum: an open trial.
    Reynoso-von Drateln C, Perla-Navarro AV, Gamez-Nava JI, Gonzalez-Lopez L, Galvan-Villegas F, Ramos-Remus C.
    J Rheumatol; 1997 Apr; 24(4):689-93. PubMed ID: 9101503
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.
    Shenefelt PD.
    Cutis; 1996 May; 57(5):315-9. PubMed ID: 8726710
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pyoderma gangrenosum: uncommon presentations.
    Ahmadi S, Powell FC.
    Clin Dermatol; 2005 May; 23(6):612-20. PubMed ID: 16325070
    [Abstract] [Full Text] [Related]

  • 10. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up.
    Saracino A, Kelly R, Liew D, Chong A.
    Australas J Dermatol; 2011 Aug; 52(3):218-21. PubMed ID: 21834821
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum.
    Seishima M, Mizutani Y, Shibuya Y, Nagasawa C, Aoki T.
    Ther Apher Dial; 2007 Jun; 11(3):177-82. PubMed ID: 17497998
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pyoderma gangrenosum: a report of 44 cases with follow-up.
    von den Driesch P.
    Br J Dermatol; 1997 Dec; 137(6):1000-5. PubMed ID: 9470924
    [Abstract] [Full Text] [Related]

  • 17. Pyoderma gangrenosum: an Indian perspective.
    Bhat RM, Nandakishore B, Sequeira FF, Sukumar D, Kamath GH, Martis J, Furtado S.
    Clin Exp Dermatol; 2011 Apr; 36(3):242-7. PubMed ID: 21070329
    [Abstract] [Full Text] [Related]

  • 18. [Pyoderma gangrenosum. 15 cases].
    Riahi I, Mokni M, Haouet S, Cherif F, El Euch D, Azaiz MI, Zitouna MM, Ben Osman-Dhahri A.
    Ann Med Interne (Paris); 2001 Feb; 152(1):3-9. PubMed ID: 11240419
    [Abstract] [Full Text] [Related]

  • 19. A novel therapy for the treatment of pyoderma gangrenosum.
    Azizan NZ, Gangaram HB, Hussein SH.
    Med J Malaysia; 2008 Mar; 63(1):51-4. PubMed ID: 18935734
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.